AlphaFold predicted structure
SMAD9 · O15198

Mean pLDDT
81.1/ 100
Confident
467 residues
Confidence breakdown
- Very high(≥ 90)63%
- Confident(70–90)12%
- Low(50–70)3%
- Very low(< 50)22%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
SMAD family member 9
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
Pulmonary arterial hypertension
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownCerebral vascular malformations
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownExtreme early-onset hypertension
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedFamilial pulmonary fibrosis
GI tract tumours
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedpulmonary hypertension, primary, 2
pulmonary arterial hypertension
heritable pulmonary arterial hypertension
idiopathic pulmonary arterial hypertension
colorectal cancer
lung cancer
Pulmonary arterial hypertension associated with congenital heart disease
benign chondrogenic neoplasm
benign colon neoplasm
colonic neoplasm
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
SMAD family member 9
Transcriptional modulator activated by BMP (bone morphogenetic proteins) type 1 receptor kinase. SMAD9 is a receptor-regulated SMAD (R-SMAD)
SMAD9 · O15198

Mean pLDDT
81.1/ 100
Confident
467 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0